nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—Epirubicin—pancreatic cancer	0.265	0.519	CrCtD
Valrubicin—Doxorubicin—pancreatic cancer	0.245	0.481	CrCtD
Valrubicin—TOP2A—Epirubicin—pancreatic cancer	0.0909	0.653	CbGbCtD
Valrubicin—Daunorubicin—Epirubicin—pancreatic cancer	0.0565	0.173	CrCrCtD
Valrubicin—Doxorubicin—Epirubicin—pancreatic cancer	0.0565	0.173	CrCrCtD
Valrubicin—Idarubicin—Epirubicin—pancreatic cancer	0.0565	0.173	CrCrCtD
Valrubicin—Daunorubicin—Doxorubicin—pancreatic cancer	0.0523	0.16	CrCrCtD
Valrubicin—Idarubicin—Doxorubicin—pancreatic cancer	0.0523	0.16	CrCrCtD
Valrubicin—Epirubicin—Doxorubicin—pancreatic cancer	0.0523	0.16	CrCrCtD
Valrubicin—TOP2A—Doxorubicin—pancreatic cancer	0.0483	0.347	CbGbCtD
Valrubicin—Proctalgia—Sunitinib—pancreatic cancer	0.000668	0.0283	CcSEcCtD
Valrubicin—Pelvic pain—Tamoxifen—pancreatic cancer	0.000602	0.0255	CcSEcCtD
Valrubicin—Skin irritation—Fluorouracil—pancreatic cancer	0.000572	0.0242	CcSEcCtD
Valrubicin—Local reaction—Fluorouracil—pancreatic cancer	0.000447	0.0189	CcSEcCtD
Valrubicin—Ageusia—Sunitinib—pancreatic cancer	0.000387	0.0164	CcSEcCtD
Valrubicin—TOP2A—Topotecan—Irinotecan—pancreatic cancer	0.000377	0.24	CbGdCrCtD
Valrubicin—Urinary incontinence—Tamoxifen—pancreatic cancer	0.000353	0.015	CcSEcCtD
Valrubicin—Rectal tenesmus—Epirubicin—pancreatic cancer	0.000323	0.0137	CcSEcCtD
Valrubicin—Rectal tenesmus—Doxorubicin—pancreatic cancer	0.000299	0.0127	CcSEcCtD
Valrubicin—Vasodilation procedure—Irinotecan—pancreatic cancer	0.000294	0.0125	CcSEcCtD
Valrubicin—Vasodilation—Irinotecan—pancreatic cancer	0.000294	0.0125	CcSEcCtD
Valrubicin—TOP2A—Paclitaxel—Docetaxel—pancreatic cancer	0.000265	0.168	CbGdCrCtD
Valrubicin—Proctalgia—Epirubicin—pancreatic cancer	0.000257	0.0109	CcSEcCtD
Valrubicin—TOP2A—Gefitinib—Erlotinib—pancreatic cancer	0.000254	0.162	CbGdCrCtD
Valrubicin—Proctalgia—Doxorubicin—pancreatic cancer	0.000238	0.0101	CcSEcCtD
Valrubicin—Blood urea increased—Gemcitabine—pancreatic cancer	0.000237	0.0101	CcSEcCtD
Valrubicin—Ageusia—Docetaxel—pancreatic cancer	0.00022	0.00934	CcSEcCtD
Valrubicin—Anorectal discomfort—Epirubicin—pancreatic cancer	0.00022	0.00933	CcSEcCtD
Valrubicin—Local reaction—Epirubicin—pancreatic cancer	0.000217	0.00922	CcSEcCtD
Valrubicin—Pneumonia—Tamoxifen—pancreatic cancer	0.000206	0.00873	CcSEcCtD
Valrubicin—Anorectal discomfort—Doxorubicin—pancreatic cancer	0.000204	0.00864	CcSEcCtD
Valrubicin—Pneumonia—Erlotinib—pancreatic cancer	0.000204	0.00864	CcSEcCtD
Valrubicin—Local reaction—Doxorubicin—pancreatic cancer	0.000201	0.00853	CcSEcCtD
Valrubicin—Urinary tract infection—Tamoxifen—pancreatic cancer	0.000199	0.00843	CcSEcCtD
Valrubicin—Pelvic pain—Epirubicin—pancreatic cancer	0.000198	0.00839	CcSEcCtD
Valrubicin—Pelvic pain—Doxorubicin—pancreatic cancer	0.000183	0.00776	CcSEcCtD
Valrubicin—Oedema peripheral—Tamoxifen—pancreatic cancer	0.000181	0.00767	CcSEcCtD
Valrubicin—Hyperglycaemia—Sunitinib—pancreatic cancer	0.000177	0.00752	CcSEcCtD
Valrubicin—Pneumonia—Sunitinib—pancreatic cancer	0.000176	0.00748	CcSEcCtD
Valrubicin—Irritability—Fluorouracil—pancreatic cancer	0.000171	0.00726	CcSEcCtD
Valrubicin—Urinary tract infection—Sunitinib—pancreatic cancer	0.00017	0.00722	CcSEcCtD
Valrubicin—Flatulence—Erlotinib—pancreatic cancer	0.000156	0.00661	CcSEcCtD
Valrubicin—Oedema peripheral—Sunitinib—pancreatic cancer	0.000155	0.00657	CcSEcCtD
Valrubicin—Back pain—Tamoxifen—pancreatic cancer	0.000155	0.00656	CcSEcCtD
Valrubicin—Back pain—Erlotinib—pancreatic cancer	0.000153	0.00649	CcSEcCtD
Valrubicin—Ageusia—Epirubicin—pancreatic cancer	0.000149	0.0063	CcSEcCtD
Valrubicin—Anaemia—Tamoxifen—pancreatic cancer	0.000148	0.00627	CcSEcCtD
Valrubicin—Pneumonia—Irinotecan—pancreatic cancer	0.000145	0.00616	CcSEcCtD
Valrubicin—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.000142	0.00603	CcSEcCtD
Valrubicin—Pneumonia—Gemcitabine—pancreatic cancer	0.000142	0.006	CcSEcCtD
Valrubicin—Pneumonia—Fluorouracil—pancreatic cancer	0.000139	0.0059	CcSEcCtD
Valrubicin—Ageusia—Doxorubicin—pancreatic cancer	0.000137	0.00583	CcSEcCtD
Valrubicin—Vasodilation—Epirubicin—pancreatic cancer	0.000137	0.00581	CcSEcCtD
Valrubicin—Vasodilation procedure—Epirubicin—pancreatic cancer	0.000137	0.00581	CcSEcCtD
Valrubicin—Myalgia—Tamoxifen—pancreatic cancer	0.000136	0.00577	CcSEcCtD
Valrubicin—Chest pain—Tamoxifen—pancreatic cancer	0.000136	0.00577	CcSEcCtD
Valrubicin—Flatulence—Sunitinib—pancreatic cancer	0.000135	0.00572	CcSEcCtD
Valrubicin—Chest pain—Erlotinib—pancreatic cancer	0.000135	0.00571	CcSEcCtD
Valrubicin—Myalgia—Erlotinib—pancreatic cancer	0.000135	0.00571	CcSEcCtD
Valrubicin—Discomfort—Tamoxifen—pancreatic cancer	0.000135	0.0057	CcSEcCtD
Valrubicin—Urinary tract infection—Fluorouracil—pancreatic cancer	0.000134	0.0057	CcSEcCtD
Valrubicin—Haematuria—Gemcitabine—pancreatic cancer	0.000134	0.00569	CcSEcCtD
Valrubicin—Back pain—Sunitinib—pancreatic cancer	0.000133	0.00562	CcSEcCtD
Valrubicin—Nocturia—Epirubicin—pancreatic cancer	0.00013	0.0055	CcSEcCtD
Valrubicin—Vasodilation—Doxorubicin—pancreatic cancer	0.000127	0.00537	CcSEcCtD
Valrubicin—Vasodilation procedure—Doxorubicin—pancreatic cancer	0.000127	0.00537	CcSEcCtD
Valrubicin—Anaemia—Sunitinib—pancreatic cancer	0.000127	0.00537	CcSEcCtD
Valrubicin—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000124	0.00527	CcSEcCtD
Valrubicin—Nocturia—Doxorubicin—pancreatic cancer	0.00012	0.00509	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000119	0.00504	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000118	0.00499	CcSEcCtD
Valrubicin—Cystitis noninfective—Epirubicin—pancreatic cancer	0.000118	0.00498	CcSEcCtD
Valrubicin—Chest pain—Sunitinib—pancreatic cancer	0.000117	0.00494	CcSEcCtD
Valrubicin—Myalgia—Sunitinib—pancreatic cancer	0.000117	0.00494	CcSEcCtD
Valrubicin—Cystitis—Epirubicin—pancreatic cancer	0.000116	0.00493	CcSEcCtD
Valrubicin—Blood urea increased—Epirubicin—pancreatic cancer	0.000114	0.00482	CcSEcCtD
Valrubicin—Flatulence—Irinotecan—pancreatic cancer	0.000111	0.00471	CcSEcCtD
Valrubicin—Back pain—Irinotecan—pancreatic cancer	0.000109	0.00463	CcSEcCtD
Valrubicin—Bladder pain—Epirubicin—pancreatic cancer	0.000109	0.00461	CcSEcCtD
Valrubicin—Cystitis noninfective—Doxorubicin—pancreatic cancer	0.000109	0.00461	CcSEcCtD
Valrubicin—Cystitis—Doxorubicin—pancreatic cancer	0.000108	0.00456	CcSEcCtD
Valrubicin—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000107	0.00453	CcSEcCtD
Valrubicin—Back pain—Gemcitabine—pancreatic cancer	0.000106	0.00451	CcSEcCtD
Valrubicin—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000106	0.00448	CcSEcCtD
Valrubicin—Blood urea increased—Doxorubicin—pancreatic cancer	0.000105	0.00446	CcSEcCtD
Valrubicin—Ill-defined disorder—Irinotecan—pancreatic cancer	0.000105	0.00444	CcSEcCtD
Valrubicin—Anaemia—Irinotecan—pancreatic cancer	0.000104	0.00442	CcSEcCtD
Valrubicin—Abdominal pain—Tamoxifen—pancreatic cancer	0.000103	0.00437	CcSEcCtD
Valrubicin—Abdominal pain—Erlotinib—pancreatic cancer	0.000102	0.00433	CcSEcCtD
Valrubicin—Body temperature increased—Erlotinib—pancreatic cancer	0.000102	0.00433	CcSEcCtD
Valrubicin—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.000102	0.00432	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000102	0.00432	CcSEcCtD
Valrubicin—Malaise—Irinotecan—pancreatic cancer	0.000102	0.00431	CcSEcCtD
Valrubicin—Anaemia—Gemcitabine—pancreatic cancer	0.000102	0.00431	CcSEcCtD
Valrubicin—Bladder pain—Doxorubicin—pancreatic cancer	0.000101	0.00427	CcSEcCtD
Valrubicin—Pneumonia—Docetaxel—pancreatic cancer	0.0001	0.00426	CcSEcCtD
Valrubicin—Anaemia—Fluorouracil—pancreatic cancer	9.99e-05	0.00424	CcSEcCtD
Valrubicin—Malaise—Gemcitabine—pancreatic cancer	9.91e-05	0.0042	CcSEcCtD
Valrubicin—TOP2A—Cytarabine—Gemcitabine—pancreatic cancer	9.56e-05	0.0608	CbGdCrCtD
Valrubicin—Discomfort—Irinotecan—pancreatic cancer	9.49e-05	0.00402	CcSEcCtD
Valrubicin—Asthenia—Tamoxifen—pancreatic cancer	9.37e-05	0.00397	CcSEcCtD
Valrubicin—Chest pain—Gemcitabine—pancreatic cancer	9.36e-05	0.00397	CcSEcCtD
Valrubicin—Myalgia—Gemcitabine—pancreatic cancer	9.36e-05	0.00397	CcSEcCtD
Valrubicin—Asthenia—Erlotinib—pancreatic cancer	9.27e-05	0.00393	CcSEcCtD
Valrubicin—Discomfort—Gemcitabine—pancreatic cancer	9.25e-05	0.00392	CcSEcCtD
Valrubicin—Pruritus—Tamoxifen—pancreatic cancer	9.24e-05	0.00392	CcSEcCtD
Valrubicin—Chest pain—Fluorouracil—pancreatic cancer	9.2e-05	0.0039	CcSEcCtD
Valrubicin—Myalgia—Fluorouracil—pancreatic cancer	9.2e-05	0.0039	CcSEcCtD
Valrubicin—Gastrointestinal pain—Sunitinib—pancreatic cancer	9.14e-05	0.00388	CcSEcCtD
Valrubicin—Pruritus—Erlotinib—pancreatic cancer	9.14e-05	0.00387	CcSEcCtD
Valrubicin—Discomfort—Fluorouracil—pancreatic cancer	9.09e-05	0.00385	CcSEcCtD
Valrubicin—Diarrhoea—Tamoxifen—pancreatic cancer	8.93e-05	0.00379	CcSEcCtD
Valrubicin—TOP2A—Doxorubicin—Epirubicin—pancreatic cancer	8.86e-05	0.0564	CbGdCrCtD
Valrubicin—TOP2A—Daunorubicin—Epirubicin—pancreatic cancer	8.86e-05	0.0564	CbGdCrCtD
Valrubicin—TOP2A—Idarubicin—Epirubicin—pancreatic cancer	8.86e-05	0.0564	CbGdCrCtD
Valrubicin—Abdominal pain—Sunitinib—pancreatic cancer	8.84e-05	0.00375	CcSEcCtD
Valrubicin—Body temperature increased—Sunitinib—pancreatic cancer	8.84e-05	0.00375	CcSEcCtD
Valrubicin—Diarrhoea—Erlotinib—pancreatic cancer	8.84e-05	0.00375	CcSEcCtD
Valrubicin—Oedema peripheral—Docetaxel—pancreatic cancer	8.83e-05	0.00374	CcSEcCtD
Valrubicin—Dizziness—Tamoxifen—pancreatic cancer	8.63e-05	0.00366	CcSEcCtD
Valrubicin—Dizziness—Erlotinib—pancreatic cancer	8.54e-05	0.00362	CcSEcCtD
Valrubicin—Vomiting—Tamoxifen—pancreatic cancer	8.3e-05	0.00352	CcSEcCtD
Valrubicin—Rash—Tamoxifen—pancreatic cancer	8.23e-05	0.00349	CcSEcCtD
Valrubicin—Dermatitis—Tamoxifen—pancreatic cancer	8.22e-05	0.00349	CcSEcCtD
Valrubicin—Vomiting—Erlotinib—pancreatic cancer	8.21e-05	0.00348	CcSEcCtD
Valrubicin—TOP2A—Idarubicin—Doxorubicin—pancreatic cancer	8.2e-05	0.0522	CbGdCrCtD
Valrubicin—TOP2A—Daunorubicin—Doxorubicin—pancreatic cancer	8.2e-05	0.0522	CbGdCrCtD
Valrubicin—TOP2A—Epirubicin—Doxorubicin—pancreatic cancer	8.2e-05	0.0522	CbGdCrCtD
Valrubicin—Headache—Tamoxifen—pancreatic cancer	8.18e-05	0.00347	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	8.18e-05	0.00347	CcSEcCtD
Valrubicin—Rash—Erlotinib—pancreatic cancer	8.15e-05	0.00345	CcSEcCtD
Valrubicin—Dermatitis—Erlotinib—pancreatic cancer	8.14e-05	0.00345	CcSEcCtD
Valrubicin—Headache—Erlotinib—pancreatic cancer	8.09e-05	0.00343	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	8.04e-05	0.00341	CcSEcCtD
Valrubicin—Asthenia—Sunitinib—pancreatic cancer	8.02e-05	0.0034	CcSEcCtD
Valrubicin—Pruritus—Sunitinib—pancreatic cancer	7.91e-05	0.00335	CcSEcCtD
Valrubicin—Nausea—Tamoxifen—pancreatic cancer	7.76e-05	0.00329	CcSEcCtD
Valrubicin—Nausea—Erlotinib—pancreatic cancer	7.67e-05	0.00325	CcSEcCtD
Valrubicin—Diarrhoea—Sunitinib—pancreatic cancer	7.65e-05	0.00324	CcSEcCtD
Valrubicin—Feeling abnormal—Irinotecan—pancreatic cancer	7.59e-05	0.00322	CcSEcCtD
Valrubicin—Back pain—Docetaxel—pancreatic cancer	7.55e-05	0.0032	CcSEcCtD
Valrubicin—Gastrointestinal pain—Irinotecan—pancreatic cancer	7.53e-05	0.00319	CcSEcCtD
Valrubicin—Dizziness—Sunitinib—pancreatic cancer	7.39e-05	0.00313	CcSEcCtD
Valrubicin—Feeling abnormal—Gemcitabine—pancreatic cancer	7.39e-05	0.00313	CcSEcCtD
Valrubicin—Abdominal pain—Irinotecan—pancreatic cancer	7.28e-05	0.00309	CcSEcCtD
Valrubicin—Body temperature increased—Irinotecan—pancreatic cancer	7.28e-05	0.00309	CcSEcCtD
Valrubicin—Feeling abnormal—Fluorouracil—pancreatic cancer	7.27e-05	0.00308	CcSEcCtD
Valrubicin—Anaemia—Docetaxel—pancreatic cancer	7.21e-05	0.00306	CcSEcCtD
Valrubicin—Vomiting—Sunitinib—pancreatic cancer	7.11e-05	0.00301	CcSEcCtD
Valrubicin—Body temperature increased—Gemcitabine—pancreatic cancer	7.09e-05	0.00301	CcSEcCtD
Valrubicin—Dysuria—Epirubicin—pancreatic cancer	7.06e-05	0.00299	CcSEcCtD
Valrubicin—Rash—Sunitinib—pancreatic cancer	7.05e-05	0.00299	CcSEcCtD
Valrubicin—Dermatitis—Sunitinib—pancreatic cancer	7.04e-05	0.00299	CcSEcCtD
Valrubicin—Headache—Sunitinib—pancreatic cancer	7.01e-05	0.00297	CcSEcCtD
Valrubicin—Pollakiuria—Epirubicin—pancreatic cancer	6.98e-05	0.00296	CcSEcCtD
Valrubicin—Body temperature increased—Fluorouracil—pancreatic cancer	6.97e-05	0.00296	CcSEcCtD
Valrubicin—TOP2A—Azacitidine—Gemcitabine—pancreatic cancer	6.85e-05	0.0436	CbGdCrCtD
Valrubicin—Hyperglycaemia—Epirubicin—pancreatic cancer	6.81e-05	0.00289	CcSEcCtD
Valrubicin—Pneumonia—Epirubicin—pancreatic cancer	6.77e-05	0.00287	CcSEcCtD
Valrubicin—Myalgia—Docetaxel—pancreatic cancer	6.64e-05	0.00282	CcSEcCtD
Valrubicin—Chest pain—Docetaxel—pancreatic cancer	6.64e-05	0.00282	CcSEcCtD
Valrubicin—Nausea—Sunitinib—pancreatic cancer	6.64e-05	0.00282	CcSEcCtD
Valrubicin—Asthenia—Irinotecan—pancreatic cancer	6.61e-05	0.0028	CcSEcCtD
Valrubicin—Urinary tract infection—Epirubicin—pancreatic cancer	6.55e-05	0.00277	CcSEcCtD
Valrubicin—Dysuria—Doxorubicin—pancreatic cancer	6.53e-05	0.00277	CcSEcCtD
Valrubicin—Pollakiuria—Doxorubicin—pancreatic cancer	6.46e-05	0.00274	CcSEcCtD
Valrubicin—Asthenia—Gemcitabine—pancreatic cancer	6.44e-05	0.00273	CcSEcCtD
Valrubicin—Haematuria—Epirubicin—pancreatic cancer	6.42e-05	0.00272	CcSEcCtD
Valrubicin—Pruritus—Gemcitabine—pancreatic cancer	6.35e-05	0.00269	CcSEcCtD
Valrubicin—Hyperglycaemia—Doxorubicin—pancreatic cancer	6.3e-05	0.00267	CcSEcCtD
Valrubicin—Diarrhoea—Irinotecan—pancreatic cancer	6.3e-05	0.00267	CcSEcCtD
Valrubicin—Pneumonia—Doxorubicin—pancreatic cancer	6.27e-05	0.00266	CcSEcCtD
Valrubicin—Pruritus—Fluorouracil—pancreatic cancer	6.24e-05	0.00265	CcSEcCtD
Valrubicin—Diarrhoea—Gemcitabine—pancreatic cancer	6.14e-05	0.0026	CcSEcCtD
Valrubicin—Dizziness—Irinotecan—pancreatic cancer	6.09e-05	0.00258	CcSEcCtD
Valrubicin—Urinary tract infection—Doxorubicin—pancreatic cancer	6.06e-05	0.00257	CcSEcCtD
Valrubicin—Diarrhoea—Fluorouracil—pancreatic cancer	6.04e-05	0.00256	CcSEcCtD
Valrubicin—Oedema peripheral—Epirubicin—pancreatic cancer	5.96e-05	0.00252	CcSEcCtD
Valrubicin—Haematuria—Doxorubicin—pancreatic cancer	5.94e-05	0.00252	CcSEcCtD
Valrubicin—Vomiting—Irinotecan—pancreatic cancer	5.86e-05	0.00248	CcSEcCtD
Valrubicin—Dizziness—Fluorouracil—pancreatic cancer	5.83e-05	0.00247	CcSEcCtD
Valrubicin—Rash—Irinotecan—pancreatic cancer	5.81e-05	0.00246	CcSEcCtD
Valrubicin—Dermatitis—Irinotecan—pancreatic cancer	5.8e-05	0.00246	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	5.8e-05	0.00246	CcSEcCtD
Valrubicin—Headache—Irinotecan—pancreatic cancer	5.77e-05	0.00245	CcSEcCtD
Valrubicin—Vomiting—Gemcitabine—pancreatic cancer	5.71e-05	0.00242	CcSEcCtD
Valrubicin—Rash—Gemcitabine—pancreatic cancer	5.66e-05	0.0024	CcSEcCtD
Valrubicin—Dermatitis—Gemcitabine—pancreatic cancer	5.65e-05	0.0024	CcSEcCtD
Valrubicin—Headache—Gemcitabine—pancreatic cancer	5.62e-05	0.00238	CcSEcCtD
Valrubicin—Vomiting—Fluorouracil—pancreatic cancer	5.61e-05	0.00238	CcSEcCtD
Valrubicin—Rash—Fluorouracil—pancreatic cancer	5.56e-05	0.00236	CcSEcCtD
Valrubicin—Dermatitis—Fluorouracil—pancreatic cancer	5.56e-05	0.00236	CcSEcCtD
Valrubicin—Headache—Fluorouracil—pancreatic cancer	5.53e-05	0.00234	CcSEcCtD
Valrubicin—Oedema peripheral—Doxorubicin—pancreatic cancer	5.51e-05	0.00234	CcSEcCtD
Valrubicin—Nausea—Irinotecan—pancreatic cancer	5.47e-05	0.00232	CcSEcCtD
Valrubicin—Nausea—Gemcitabine—pancreatic cancer	5.33e-05	0.00226	CcSEcCtD
Valrubicin—Feeling abnormal—Docetaxel—pancreatic cancer	5.25e-05	0.00222	CcSEcCtD
Valrubicin—Nausea—Fluorouracil—pancreatic cancer	5.24e-05	0.00222	CcSEcCtD
Valrubicin—Gastrointestinal pain—Docetaxel—pancreatic cancer	5.21e-05	0.00221	CcSEcCtD
Valrubicin—Flatulence—Epirubicin—pancreatic cancer	5.19e-05	0.0022	CcSEcCtD
Valrubicin—Back pain—Epirubicin—pancreatic cancer	5.09e-05	0.00216	CcSEcCtD
Valrubicin—Abdominal pain—Docetaxel—pancreatic cancer	5.03e-05	0.00213	CcSEcCtD
Valrubicin—Body temperature increased—Docetaxel—pancreatic cancer	5.03e-05	0.00213	CcSEcCtD
Valrubicin—Ill-defined disorder—Epirubicin—pancreatic cancer	4.88e-05	0.00207	CcSEcCtD
Valrubicin—Anaemia—Epirubicin—pancreatic cancer	4.86e-05	0.00206	CcSEcCtD
Valrubicin—Flatulence—Doxorubicin—pancreatic cancer	4.8e-05	0.00203	CcSEcCtD
Valrubicin—Malaise—Epirubicin—pancreatic cancer	4.75e-05	0.00201	CcSEcCtD
Valrubicin—Back pain—Doxorubicin—pancreatic cancer	4.71e-05	0.002	CcSEcCtD
Valrubicin—Asthenia—Docetaxel—pancreatic cancer	4.57e-05	0.00194	CcSEcCtD
Valrubicin—Ill-defined disorder—Doxorubicin—pancreatic cancer	4.52e-05	0.00192	CcSEcCtD
Valrubicin—Pruritus—Docetaxel—pancreatic cancer	4.51e-05	0.00191	CcSEcCtD
Valrubicin—Anaemia—Doxorubicin—pancreatic cancer	4.5e-05	0.00191	CcSEcCtD
Valrubicin—Chest pain—Epirubicin—pancreatic cancer	4.48e-05	0.0019	CcSEcCtD
Valrubicin—Myalgia—Epirubicin—pancreatic cancer	4.48e-05	0.0019	CcSEcCtD
Valrubicin—Discomfort—Epirubicin—pancreatic cancer	4.43e-05	0.00188	CcSEcCtD
Valrubicin—Malaise—Doxorubicin—pancreatic cancer	4.39e-05	0.00186	CcSEcCtD
Valrubicin—Diarrhoea—Docetaxel—pancreatic cancer	4.36e-05	0.00185	CcSEcCtD
Valrubicin—Dizziness—Docetaxel—pancreatic cancer	4.21e-05	0.00178	CcSEcCtD
Valrubicin—Myalgia—Doxorubicin—pancreatic cancer	4.15e-05	0.00176	CcSEcCtD
Valrubicin—Chest pain—Doxorubicin—pancreatic cancer	4.15e-05	0.00176	CcSEcCtD
Valrubicin—Discomfort—Doxorubicin—pancreatic cancer	4.1e-05	0.00174	CcSEcCtD
Valrubicin—Vomiting—Docetaxel—pancreatic cancer	4.05e-05	0.00172	CcSEcCtD
Valrubicin—Rash—Docetaxel—pancreatic cancer	4.01e-05	0.0017	CcSEcCtD
Valrubicin—Dermatitis—Docetaxel—pancreatic cancer	4.01e-05	0.0017	CcSEcCtD
Valrubicin—Headache—Docetaxel—pancreatic cancer	3.99e-05	0.00169	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	3.91e-05	0.00166	CcSEcCtD
Valrubicin—Nausea—Docetaxel—pancreatic cancer	3.78e-05	0.0016	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	3.62e-05	0.00153	CcSEcCtD
Valrubicin—Feeling abnormal—Epirubicin—pancreatic cancer	3.54e-05	0.0015	CcSEcCtD
Valrubicin—Gastrointestinal pain—Epirubicin—pancreatic cancer	3.51e-05	0.00149	CcSEcCtD
Valrubicin—Body temperature increased—Epirubicin—pancreatic cancer	3.4e-05	0.00144	CcSEcCtD
Valrubicin—Abdominal pain—Epirubicin—pancreatic cancer	3.4e-05	0.00144	CcSEcCtD
Valrubicin—Feeling abnormal—Doxorubicin—pancreatic cancer	3.27e-05	0.00139	CcSEcCtD
Valrubicin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.25e-05	0.00138	CcSEcCtD
Valrubicin—Abdominal pain—Doxorubicin—pancreatic cancer	3.14e-05	0.00133	CcSEcCtD
Valrubicin—Body temperature increased—Doxorubicin—pancreatic cancer	3.14e-05	0.00133	CcSEcCtD
Valrubicin—Asthenia—Epirubicin—pancreatic cancer	3.08e-05	0.00131	CcSEcCtD
Valrubicin—Pruritus—Epirubicin—pancreatic cancer	3.04e-05	0.00129	CcSEcCtD
Valrubicin—Diarrhoea—Epirubicin—pancreatic cancer	2.94e-05	0.00125	CcSEcCtD
Valrubicin—Asthenia—Doxorubicin—pancreatic cancer	2.85e-05	0.00121	CcSEcCtD
Valrubicin—Dizziness—Epirubicin—pancreatic cancer	2.84e-05	0.0012	CcSEcCtD
Valrubicin—Pruritus—Doxorubicin—pancreatic cancer	2.81e-05	0.00119	CcSEcCtD
Valrubicin—Vomiting—Epirubicin—pancreatic cancer	2.73e-05	0.00116	CcSEcCtD
Valrubicin—Diarrhoea—Doxorubicin—pancreatic cancer	2.72e-05	0.00115	CcSEcCtD
Valrubicin—Rash—Epirubicin—pancreatic cancer	2.71e-05	0.00115	CcSEcCtD
Valrubicin—Dermatitis—Epirubicin—pancreatic cancer	2.71e-05	0.00115	CcSEcCtD
Valrubicin—Headache—Epirubicin—pancreatic cancer	2.69e-05	0.00114	CcSEcCtD
Valrubicin—Dizziness—Doxorubicin—pancreatic cancer	2.63e-05	0.00111	CcSEcCtD
Valrubicin—Nausea—Epirubicin—pancreatic cancer	2.55e-05	0.00108	CcSEcCtD
Valrubicin—Vomiting—Doxorubicin—pancreatic cancer	2.53e-05	0.00107	CcSEcCtD
Valrubicin—Rash—Doxorubicin—pancreatic cancer	2.51e-05	0.00106	CcSEcCtD
Valrubicin—Dermatitis—Doxorubicin—pancreatic cancer	2.5e-05	0.00106	CcSEcCtD
Valrubicin—Headache—Doxorubicin—pancreatic cancer	2.49e-05	0.00106	CcSEcCtD
Valrubicin—Nausea—Doxorubicin—pancreatic cancer	2.36e-05	0.001	CcSEcCtD
